Exploring the anti-tumour activity of bisphosphonates in early breast cancer

Cancer Treatment Reviews
M C WinterRobert E Coleman

Abstract

Bisphosphonates are potent inhibitors of osteoclast-mediated bone resorption and are firmly established in the management of breast cancer patients with metastatic skeletal disease. There are extensive data that bisphosphonates, particularly nitrogen-containing bisphosphonates such as zoledronic acid, exhibit anti-tumour activity potentially via both indirect and direct mechanisms in vitro. In vivo studies using animal models of breast cancer induced bone disease have shown that bisphosphonates exert anti-tumour effects via inhibiting osteolysis and reducing skeletal tumour burden. Furthermore, pre-clinical studies have demonstrated synergistic anti-tumour effects between chemotherapy agents commonly used in breast cancer treatment and nitrogen-containing bisphosphonates. This, coupled with emerging evidence from pre-clinical in vivo studies suggesting that bisphosphonates may have additional anti-tumour activity outside of the bone microenvironment, could be of significant importance in the clinical management of breast cancer. The evidence in favour of an anti-tumour effect of bisphosphonates in the clinical setting is inconclusive however, with conflicting evidence from several trials. This review focuses on the anti-tumour ...Continue Reading

References

Dec 4, 1992·Annals of the New York Academy of Sciences·H F DvorakD R Senger
Nov 1, 1992·The Journal of Cell Biology·Y GavrieliS A Ben-Sasson
Nov 18, 1971·The New England Journal of Medicine·J Folkman
Jun 1, 1996·Endocrinology·C RaynalC Chenu
Aug 1, 1996·The Journal of Clinical Investigation·G van der PluijmS Papapoulos
Jul 3, 1998·International Journal of Cancer. Journal International Du Cancer·A SasakiT Matsumura
Aug 6, 1998·The New England Journal of Medicine·I J DielG Bastert
Feb 19, 1999·Journal of Clinical Pathology·P J van DiestJ P Baak
Jun 23, 2001·BMJ : British Medical Journal·A G RenehanC S Potten
Aug 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Trevor PowlesLiisa Pylkkänen
Aug 3, 2002·Nature Reviews. Cancer·Gregory R Mundy
Aug 17, 2002·The Journal of Pharmacology and Experimental Therapeutics·Jeanette WoodJonathan R Green
Sep 19, 2002·Endocrine-related Cancer·S CleatorM Dowsett
Oct 2, 2002·Breast Cancer Research and Treatment·Toshimi MichigamiToshiyuki Yoneda
Oct 3, 2002·Journal of the National Cancer Institute·Fred SaadUNKNOWN Zoledronic Acid Prostate Cancer Study Group
Nov 5, 2002·Journal of Clinical Pharmacology·Tianling ChenAndrej Skerjanec
Feb 4, 2003·American Journal of Clinical Oncology·Robert E Coleman
Feb 7, 2003·Current Medicinal Chemistry·Philippe ClézardinOlivier Peyruchaud
Aug 15, 2003·International Journal of Cancer. Journal International Du Cancer·Toru HiragaToshiyuki Yoneda
Sep 25, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D SantiniG Tonini
May 28, 2004·Endocrine-related Cancer·Janet E BrownRobert E Coleman
Jun 29, 2004·Journal of Clinical Pathology·P J van DiestJ P A Baak
Jul 9, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Toru HiragaToshiyuki Yoneda
Sep 30, 2004·International Journal of Cancer. Journal International Du Cancer·Helen L Neville-WebbeIngunn Holen
Oct 2, 2004·The Oncologist·Jonathan R Green
Mar 2, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Norio KohnoShigemitsu Takashima
Jun 17, 2005·Cancer Research·Philippe ClézardinPierrick G J Fournier
Aug 13, 2005·Anti-cancer Drugs·Julia K L WoodwardIngunn Holen

❮ Previous
Next ❯

Citations

Jan 20, 2012·Der Urologe. Ausg. A·F Moltzahn, G N Thalmann
Apr 1, 2010·International Journal of Clinical Oncology·Mohamed S ZaghloulMohamed Nazmy
Apr 12, 2012·International Journal of Clinical Oncology·Hiroji UemuraUNKNOWN Yokohama Bone Metastasis Study Group
May 22, 2010·Breast Cancer Research and Treatment·Allan Lipton
Oct 12, 2011·Breast Cancer Research and Treatment·Dulcinea Candelaria-QuintanaMelanie E Royce
Feb 28, 2013·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·M AlcarazD Achel
Aug 31, 2011·Prostate Cancer and Prostatic Diseases·H K KoulR B Meacham
Feb 14, 2009·The New England Journal of Medicine·Michael GnantC Marth
Oct 31, 2009·The Journal of Biological Chemistry·Laura M MitrofanJukka Mönkkönen
May 7, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H EidtmannR Coleman
Mar 24, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A M VandoneM Scoletta
Mar 3, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E-F SolomayerT Fehm
Jun 26, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P HadjiJ Green
Jul 22, 2011·Journal of the National Cancer Institute·Kathrin BauerNicole Skoetz
Oct 25, 2011·Journal of the National Cancer Institute·Genevieve M MonseesChristopher I Li
Apr 4, 2006·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·H L Neville-WebbeI Holen
Nov 1, 2009·Therapeutic Advances in Medical Oncology·Michael GnantRaimund Jakesz
Feb 16, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gad RennertStephen B Gruber
Oct 2, 2009·Magyar onkologia·Lilla Tamási
Oct 11, 2012·Cancer Management and Research·Draupadi B Talreja
Nov 16, 2012·International Journal of Women's Health·Rebecca Aft
Dec 20, 2008·Drugs·Katherine A Lyseng-Williamson
Feb 8, 2014·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·P HadjiM Bauer
Mar 4, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A CharehbiliUNKNOWN Dutch Breast Cancer Research Group (BOOG)
May 14, 2010·Breast Cancer Research and Treatment·Catherine Van Poznak
Feb 28, 2009·Women's Health·Martin Pecherstorfer
Feb 22, 2012·Expert Opinion on Biological Therapy·Julie R NangiaMeghana V Trivedi
Apr 26, 2013·Expert Opinion on Drug Safety·Jean-Yves ReginsterOlivier Bruyère
Aug 9, 2011·Current Eye Research·Alvin Eisner, Shiuh-Wen Luoh
Dec 25, 2010·Climacteric : the Journal of the International Menopause Society·P Hadji

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis